B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
about
Rituximab for relapsing-remitting multiple sclerosisB Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic InterventionsB Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized InflammationCytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisCD8(+) T-Cells as Immune Regulators of Multiple SclerosisB Cells and Autoantibodies in Multiple SclerosisInterleukin-35: Expanding Its Job ProfileGut commensalism, cytokines, and central nervous system demyelinationVaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?The dopaminergic system in autoimmune diseasesCD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent modelRestoring immune tolerance in neuromyelitis optica: Part IISpotlight on tocilizumab and its potential in the treatment of systemic sclerosisNeuroinflammation: Ways in Which the Immune System Affects the BrainBANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1/2/eIF4E translation initiation pathwayB cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.Dimethyl fumarate alters B-cell memory and cytokine production in MS patientsInvolvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity.In search of magic bullets: the golden age of immunotherapeutics.The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosisInduction of interleukin-6 production by rituximab in human B cells.Immunology of IgG4-related disease.Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosisActivated peritoneal cavity B-1a cells possess regulatory B cell properties.The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice.Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.Single dose of glycoengineered anti-CD19 antibody (MEDI551) disrupts experimental autoimmune encephalomyelitis by inhibiting pathogenic adaptive immune responses in the bone marrow and spinal cord while preserving peripheral regulatory mechanisms.Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligandUptake and presentation of myelin basic protein by normal human B cells.Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets
P2860
Q24201928-157D5BCC-5772-4745-B0CD-90296B91F65CQ26770664-BC3AEC07-F5F5-4CE5-87BA-D6F221689FB3Q26770852-A155F66F-BD52-446B-8B45-440CB60235BDQ26771459-068C4BF5-0130-472B-8BB0-FF3DD027958AQ26772339-C76EC2E1-3543-4928-A4AD-81209853F201Q26801386-1091DD81-CA5A-4438-91D0-2BD7B77B164AQ26829619-02566D82-5626-47C3-956A-FC5F73F328FEQ26863405-7A38262C-B84C-4719-B716-8254B71E97F8Q27015811-61982B63-6A9F-4284-836A-DC06E8ACA8C5Q27023885-4D757CCC-A3A3-4D49-8284-215071DEF2BFQ27318165-1A63FF4A-8E1D-4AD3-9D7A-5CC249A5C106Q28070136-5A336B5C-0F40-45F4-A4DA-6033BE1EC4BAQ28073706-791244FD-41E4-488F-BAF4-6D17E75B2658Q28080620-F66F10EF-FC0B-47B0-82D8-62EA74CAC263Q28512739-3EF28B49-B9E6-4406-A2A8-7655922BE1ADQ33404838-2C867D00-70F4-406B-A744-B92AEE075A53Q33585268-697AFD77-0DF2-4733-91DB-CB68460B964AQ33616360-C968EC72-26DB-47B4-8721-E6B4DB897CB9Q33646238-2769808A-8C13-447A-9F07-0B937FFA0A53Q33988247-567E003F-FC35-4DE9-94A3-D2E81EE6D599Q34066554-654ED148-EF37-4CCE-B94E-4486990051E4Q34287001-48DBF3F6-7A21-4F8E-8907-3AB1D19A6C68Q34356481-E4A6B0E9-EB0F-4F1D-BD1D-0475BDAC6B33Q34413247-88DBB388-F800-4CDA-97A0-196462FF1DEDQ34415869-81435309-7F8B-4C1F-9F63-97D9B2A04C47Q34471314-FD700AE0-BE27-47AA-A988-B581EB34012EQ34587471-11158CD3-656D-45E3-AE76-3277CB9BB1B8Q34626114-70AC56C7-C5AD-4431-B6B8-F33DAA59568AQ34658996-BBD20162-E282-4EB8-BAB3-68C7A73154FAQ34687561-507050DC-EADF-40E6-91A7-C7FA4FAB2985Q34721223-E8561124-6C13-4E92-9CE5-884E59B0734DQ35025511-264388E8-B294-4E97-ACFF-DC16A09222B1Q35097618-9E792EB6-923E-4862-B260-56B724311B5DQ35105313-03940562-2CDD-44B5-91F5-6B22C362E5CBQ35122990-D374BFAE-DB35-4340-B8E5-C80050929C29Q35186239-DAAF7D15-71F0-44BE-8CA6-F75460A2DF4AQ35216023-79459DAC-0F87-46E0-9689-BD0B9DC424DDQ35302329-3CE31E73-618C-4387-ACEF-7F1CF4C19998Q35424431-2341E01C-1A57-4542-890C-BC938253F83BQ35463552-9E4A6BC2-F2BC-4AFF-99F2-593A255B6672
P2860
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
B cell depletion therapy ameli ...... tion of IL-6-producing B cells
@ast
B cell depletion therapy ameli ...... tion of IL-6-producing B cells
@en
type
label
B cell depletion therapy ameli ...... tion of IL-6-producing B cells
@ast
B cell depletion therapy ameli ...... tion of IL-6-producing B cells
@en
prefLabel
B cell depletion therapy ameli ...... tion of IL-6-producing B cells
@ast
B cell depletion therapy ameli ...... tion of IL-6-producing B cells
@en
P2093
P2860
P50
P356
P1476
B cell depletion therapy ameli ...... tion of IL-6-producing B cells
@en
P2093
Amit Bar-Or
David Gray
Richard A O'Connor
Sarah Lawrie
Stephen M Anderton
Tom A Barr
Vicky Lampropoulou
P2860
P304
P356
10.1084/JEM.20111675
P407
P577
2012-04-30T00:00:00Z